BC Innovations | Sep 6, 2012
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) Ryanodine receptor 1 (RyR1) In vitro and mouse studies suggest inhibiting RyR1 could help treat AD. In neuroblastoma cell lines and mouse...
Items per page:
1 - 1 of 1